Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3)

 REVIEW FREEfree

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):247-70

Advances in radioguided surgery in oncology

Renato A. VALDÉS OLMOS, Sergi VIDAL-SICART, Gianpiero MANCA, Giuliano MARIANI, Luisa F. LEÓN-RAMÍREZ, Domenico RUBELLO, Francesco GIAMMARILE *


 REVIEW FREEfree

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):271-82

Role for imaging in spondyloarthritis

Jun RAN, John N. MORELLI, Ruyi XIE, Xiaoli ZHANG, Xiaoqing LIANG, Xuanlin LIU, Xiaoming LI *


 REVIEW FREEfree

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):283-91

Evaluation of diabetic foot infection in nuclear medicine

Sherif HEIBA *, Karin KNEŠAUREK


 REVIEW FREEfree

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):292-300

Imaging of primary liver tumors with positron-emission tomography

Alexander R. HAUG *


 ORIGINAL ARTICLE FREEfree

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):301-13

18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology

Koutoua J. ANOUAN, Benoît LELANDAIS, Agathe EDET‑SANSON, Su RUAN, Pierre VERA, Isabelle GARDIN, Sebastien HAPDEY *


 ORIGINAL ARTICLE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):314-22

Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer

Ummuhan ABDULREZZAK *, Ahmet TUTUS, Ilknur ISIK, Yurdagul KURT, Mustafa KULA


 ORIGINAL ARTICLE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):323-30

Clinical significance of hemodynamic cerebral ischemia on cognitive function in carotid artery stenosis: a prospective study before and after revascularization

Naoki AKIOKA *, Akiko TAKAIWA, Daina KASHIWAZAKI, Naoya KUWAYAMA, Shunro ENDO, Satoshi KURODA


 ORIGINAL ARTICLE 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):331-9

Discrepant salivary gland response after radioiodine and MIBG therapies

Walter JENTZEN *, Marion RICHTER, Thorsten D. POEPPEL, Jochen SCHMITZ, Wolfgang BRANDAU, Andreas BOCKISCH, Ina BINSE


inizio pagina